八月三十一日，著名华裔蛋白质生物科学家薛瑜(Yu Xue)被控窃取葛兰素史克（GSK）癌症治疗药物的“机密”被美帝国费城联邦法院指控犯有偷窃商业机密罪。很不幸的是薛瑜最终认罪，有可能面临10年监禁、25万美元罚款和20亿美元赔偿金（赔偿GSK）。

这对于一位48岁的年轻科学家而言无疑是灾难性的。让人深感惋惜！

自川普上任以来，针对华裔人士“窃取”美国及西方科技机密的查处力度日益加大。

薛瑜案只是刚开始，还有5名华裔科学家涉嫌其中，并面对45项指控，这些人将在接下来的9月和10月接受审查...

据认为薛瑜在GSK任职期间曾通过电子邮件向Tao Li(“李涛”)发送据说是GSK的商业机密...

以助其成立“南京信诺药业（RenoPharma)...

此事最初发生在2016年1月，时至上月才有了审理结论：

Two researchers accused of passing research data and manufacturing details to Chinese firm

Two scientists working at GlaxoSmithKline (GSK)in Pennsylvania, US, have been indicted for conspiracy to commit fraud and allegedly stealing confidential information related to its biopharmaceutical products. The indictment names five people, including scientists Yu Xue and Lucy Xi. If convicted of all charges, each defendant faces a range of punishments, including fines and possible prison terms.

The indictment claims that Xue and Xi used e-mail and USB drives to transmit information about GSK’s procedures for researching, developing, and manufacturing biopharmaceutical products designed to treat cancer or other diseases. Xue and two of the other defendants had formed a company in China called Renopharma in July 2012, allegedly to market and sell the stolen trade secret information.